|
Gil-Candel M, Gascon-Canovas JJ, Urbieta-Sanz E, Rentero-Redondo L, Onteniente-Candela M, Iniesta-Navalon C. Comparison of drug survival between infliximab and adalimumab in inflammatory bowel disease. Int J Clin Pharm. 2020 Apr;42(2):500-507. doi: 10.1007/s11096-020-00978-6. Epub 2020 Jan 31. PubMed PMID: 32006141.
AÑO: 2020; IF: 2.054
|
32006141
|
Iniesta-Navalon C, Gascon-Canovas JJ, Gama ZADS, Sanchez-Ruiz JF, Gutierrez-Estrada EA, De-la-Cruz-Sanchez E, Harrington-Fernandez O. Potential and clinical relevant drug-drug interactions among elderly from nursing homes: a multicentre study in Murcia, Spain. Cien Saude Colet. 2019 May 30;24(5):1895-1902. doi: 10.1590/1413-81232018245.16032017. PubMed PMID: 31166522.
AÑO: 2019; IF: 1.019
|
|
Caballero Requejo C, Urbieta Sanz E, Iniesta Navalon C, Gascon Canovas JJ. [Incorporation of direct-acting oral anticoagulants to available therapeutic arsenal: Progress adequately?]. Aten Primaria. 2019 Mar;51(3):184-185. doi: 10.1016/j.aprim.2018.11.004. Epub 2019 Jan 17. No abstract available. Spanish. PubMed PMID: 30660438; PubMed Central PMCID: PMC6837083.
AÑO: 2019; IF: 1.087
|
|
Iniesta-Navalón C, Franco-Miguel JJ, Gascón-Cánovas JJ, Rentero-Redondo L. Effect of drug interactions involving antiretroviral drugs on viral load in HIV population. Eur J Hosp Pharm. 2016 Jul;23(4):241-243. doi: 10.1136/ejhpharm-2015-000670. Epub 2015 Jun 18. PubMed PMID: 31156857; PubMed Central PMCID: PMC6451441.
AÑO: 2016; IF: 0.718
|
|
Iniesta-Navalón C, Franco-Miguel JJ, Gascón-Cánovas JJ, Rentero-Redondo L. Identification of potential clinically significant drug interactions in HIV-infected patients: a comprehensive therapeutic approach. HIV Med. 2015 May;16(5):273-9. doi: 10.1111/hiv.12205. Epub 2014 Dec 18. PubMed PMID: 25523089.
AÑO: 2015; IF: 3.556
|